• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺细针穿刺活检中意义未明的滤泡性病变再探讨。

Follicular lesion of undetermined significance in thyroid FNA revisited.

作者信息

Walts Ann E, Mirocha James, Bose Shikha

机构信息

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

Diagn Cytopathol. 2014 Jan;42(1):18-22. doi: 10.1002/dc.23019. Epub 2013 Jul 27.

DOI:10.1002/dc.23019
PMID:23894017
Abstract

Controversy exists regarding the validity of follicular lesion of undetermined significance (FLUS), an indeterminate diagnostic category of The Bethesda System for Reporting Thyroid Cytopathology (BSRTC). According to BSRTC, FLUS carries a 5-15% risk of cancer. This study was designed to determine if cytomorphology could stratify FLUS into subgroups with different risks of malignancy. Reports of 127 consecutive FNAs reported as FLUS with subsequent tissue diagnoses were evaluated for the presence of various cytologic features and the results were correlated with histological diagnoses. FLUS cases with focal nuclear atypia (nuclear overlap/crowding, nuclear grooves/membrane irregularities, nuclear enlargement, and/or nuclear pseudoinclusions) were more frequently malignant on excision whereas those with architectural atypia (microfollicles) were more often benign on excision (P < 0.05). The presence of any one or more of these nuclear features increased the risk of carcinoma in subsequent thyroid resection. Papillary carcinomas predominated in excised FLUS cases with focal nuclear atypia whereas most FLUS with architectural atypia were adenomas or hyperplastic nodules on histological evaluation. BSRTC recommends that thyroid aspirates containing follicular cell nuclear and/or architectural atypia insufficient for a diagnosis of suspicious for follicular neoplasm, suspicious for malignancy or malignant be classified as FLUS. Our findings indicate that FLUS cases with focal nuclear atypia carry a risk for malignancy that is substantially higher than that assigned to FLUS and are best classified as suspicious. FLUS cases lacking these atypical nuclear features have a risk for malignancy that approximates the risk BSRTC has assigned to FLUS.

摘要

关于意义未明的滤泡性病变(FLUS)这一甲状腺细胞病理学报告的贝塞斯达系统(BSRTC)中的不确定诊断类别,其有效性存在争议。根据BSRTC,FLUS的癌症风险为5%-15%。本研究旨在确定细胞形态学是否能将FLUS分层为具有不同恶性风险的亚组。对127例连续细针穿刺抽吸活检(FNA)报告为FLUS且随后有组织学诊断的病例进行评估,以确定各种细胞学特征的存在情况,并将结果与组织学诊断相关联。具有局灶性核异型性(核重叠/拥挤、核沟/膜不规则、核增大和/或核假包涵体)的FLUS病例在切除时更常为恶性,而具有结构异型性(微滤泡)的病例在切除时更常为良性(P<0.05)。这些核特征中任何一种或多种的存在都会增加后续甲状腺切除术中癌的风险。在具有局灶性核异型性的切除FLUS病例中,乳头状癌占主导,而在组织学评估中,大多数具有结构异型性的FLUS为腺瘤或增生性结节。BSRTC建议,甲状腺抽吸物中含有不足以诊断为滤泡性肿瘤可疑、恶性可疑或恶性的滤泡细胞核和/或结构异型性应分类为FLUS。我们的研究结果表明,具有局灶性核异型性的FLUS病例的恶性风险显著高于赋予FLUS的风险,最好分类为可疑。缺乏这些非典型核特征的FLUS病例的恶性风险接近BSRTC赋予FLUS的风险。

相似文献

1
Follicular lesion of undetermined significance in thyroid FNA revisited.甲状腺细针穿刺活检中意义未明的滤泡性病变再探讨。
Diagn Cytopathol. 2014 Jan;42(1):18-22. doi: 10.1002/dc.23019. Epub 2013 Jul 27.
2
The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.应用亚分类和 BRAF 突变结果对甲状腺细胞病理学报告的 Bethesda 系统中“意义不明确的非典型性/滤泡性病变意义不明确”类别进行恶性风险预测。
Cancer Cytopathol. 2014 May;122(5):368-76. doi: 10.1002/cncy.21396. Epub 2014 Mar 3.
3
The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.意义不明确的非典型性/滤泡性病变及重复细针穿刺活检的影响:贝塞斯达系统实施前后5年
Cancer Cytopathol. 2014 Dec;122(12):866-72. doi: 10.1002/cncy.21468. Epub 2014 Jul 30.
4
Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.甲状腺细针穿刺细胞学检查中不典型病变及意义未明的滤泡性病变的随访
Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18.
5
Subclassification of Bethesda Atypical and Follicular Neoplasm Categories According to Nuclear and Architectural Atypia Improves Discrimination of Thyroid Malignancy Risk.根据核和结构异型性对 Bethesda 不典型和滤泡性肿瘤类别的细分可提高甲状腺恶性风险的鉴别能力。
Thyroid. 2018 Apr;28(4):511-521. doi: 10.1089/thy.2017.0274. Epub 2018 Mar 29.
6
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
7
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.不同的 AUS/FLUS 甲状腺细针穿刺活检的界限标准具有不同的 BRAF、RAS、RET/PTC 和 PAX8/PPARg 改变。
Cancer Cytopathol. 2018 May;126(5):317-325. doi: 10.1002/cncy.21984. Epub 2018 Feb 22.
8
Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases.使用贝塞斯达系统对以前不确定的甲状腺细针穿刺活检结果进行重新分类可减少不确定病例的数量。
Acta Cytol. 2012;56(2):122-9. doi: 10.1159/000334200. Epub 2012 Feb 17.
9
Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.使用2015年美国甲状腺协会(ATA)指南定义的超声模式对具有意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS)细胞学特征的甲状腺结节进行风险分层。
Ann Otol Rhinol Laryngol. 2017 Sep;126(9):625-633. doi: 10.1177/0003489417719472. Epub 2017 Jul 18.
10
Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.当审阅来自不同机构的玻片时,使用贝塞斯达系统报告甲状腺细胞学检查结果,对意义不明确的非典型性病变/意义不明确的滤泡性病变类别进行再现性研究:细胞病理学家间的观察者间变异性研究
Diagn Cytopathol. 2017 May;45(5):399-405. doi: 10.1002/dc.23681. Epub 2017 Feb 20.

引用本文的文献

1
The Efficacy of Bethesda System for Prediction of Thyroid Malignancies- A 9 Year Experience from a Tertiary Center.贝塞斯达系统对甲状腺恶性肿瘤的预测效能——来自三级医疗中心的9年经验
Iran J Otorhinolaryngol. 2021 Jul;33(117):209-215. doi: 10.22038/ijorl.2021.50538.2687.
2
Atypia of undetermined significance/follicular lesion of undetermined significance: Asian non-Asian practice, and the Singapore experience.意义不明确的非典型性/意义不明确的滤泡性病变:亚洲与非亚洲的实践及新加坡经验
Gland Surg. 2020 Oct;9(5):1764-1787. doi: 10.21037/gs-20-555.
3
Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Bethesda III 和 IV 甲状腺结节的恶性率:细针穿刺细胞学与组织病理学相关性的回顾性研究。
BMC Endocr Disord. 2020 Apr 15;20(1):48. doi: 10.1186/s12902-020-0530-9.
4
Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?目前的分子检测能否有助于诊断甲状腺结节细针穿刺活检结果不确定的情况?
Arch Endocrinol Metab. 2018;62(6):576-584. doi: 10.20945/2359-3997000000081.
5
Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.核异型性在细胞学不确定的甲状腺结节中与癌症风险的相关性:系统评价和荟萃分析。
Thyroid. 2018 Feb;28(2):210-219. doi: 10.1089/thy.2017.0419. Epub 2017 Dec 21.
6
The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology.CD56在甲状腺细针穿刺细胞学中的作用:一项基于液基细胞学的初步研究
PLoS One. 2015 Jul 17;10(7):e0132939. doi: 10.1371/journal.pone.0132939. eCollection 2015.
7
The Bethesda system for reporting thyroid cytopathology: a single-center experience over 5 years.贝塞斯达甲状腺细胞病理学报告系统:5年单中心经验
Ann Surg Oncol. 2014 Oct;21(11):3522-7. doi: 10.1245/s10434-014-3743-1. Epub 2014 May 6.
8
Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).甲状腺结节分类为贝塞斯达Ⅲ类(不典型/意义未明的滤泡性病变)的恶性率。
Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.